Conditions | Without COPD | With COPD | P-valuec |
---|---|---|---|
(n = 14,828)a | (n = 995)b | ||
Diseases | |||
CHF, %, (95% CI) | 3.9 (3.6–4.3) | 12.1 (9.8–14.8) | <.0001 |
CHD, %, (95% CI) | 6.1 (5.5–6.7) | 12.7 (10.5–15.3) | <.0001 |
HTN, %, (95% CI) | 52.2 (50.7–53.7) | 60.4 (55.8–64.8) | 0.0006 |
High cholesterol, %, (95% CI) | 41.3 (39.9–42.6) | 47.6 (43.0–52.2) | 0.0096 |
CVA, %, (95% CI) | 4.6 (4.2–5.0) | 8.9 (7.0–11.1) | <.0001 |
Diabetes, %, (95% CI) | 12.8 (12.1–13.7) | 16.3 (13.3–19.8) | 0.0184 |
Osteoporosis, %, (95% CI) | 8.5 (7.8–9.2) | 16.9 (13.7–20.7) | <.0001 |
Arthritis, %, (95% CI) | 36.9 (35.6–38.2) | 54.6 (49.8–59.3) | <.0001 |
Cancer, %, (95% CI) | 9.9 (9.3–10.6) | 16.5 (14.2–19.0) | <.0001 |
Depression, %, (95% CI) | 12.5 (11.8–13.3) | 20.6 (17.1–24.6) | <.0001 |
Anxiety, %, (95% CI) | 3.8 (3.3–4.3) | 8.6 (6.6–11.1) | <.0001 |
Clinical Factors | |||
Dizziness/Balance Problems, %, (95% CI)d | 23.8 (22.4–25.4) | 41.1 (36.3–46.1) | <.0001 |
Obesity, %, (95% CI) | 33.5 (32.0–35.1) | 40.3 (36.4–44.4) | 0.0013 |
Urinary Incontinence, %, (95% CI) | 27.3 (26.1–28.7) | 34.9 (29.6–40.5) | 0.0048 |
Anemia, %, (95% CI) | 6.2 (5.5–7.1) | 9.3 (7.1–12.0) | 0.0030 |
Low GFR, %, (95% CI) | 10.5 (9.7–11.2) | 16.2 (13.3–19.5) | <.0001 |
>4 meds, %, (95% CI) | 32.1 (30.5–33.8) | 51.8 (46.2–57.2) | 0.0022 |
Frailty, %, (95% CI) | 3.1 (2.7–3.6) | 9.5 (7.0–12.8) | <.0001 |
Health Status Factors | |||
Memory problems, %, (95% CI) | 8.8 (8.1–9.5) | 18.5 (14.9–22.7) | <.0001 |
Mobility difficulty, %, (95% CI) | 32.5 (30.7–34.4) | 55.6 (50.6–60.5) | <.0001 |
Hearing impairment, %, (95% CI) | 8.3 (7.7–8.9) | 12.1 (9.8–14.9) | 0.0008 |
Visual impairment, %, (95% CI) | 9.6 (9.0–10.3) | 14.0 (12.0–16.2) | <.0001 |
All Conditions | |||
> = 1 comorbid condition, %, (95% CI) | 87.7 (86.4–88.8) | 96.4 (94.3–97.8) | <.0001 |